GALECTIN THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.34 USD | -3.31% |
|
-10.69% | +40.96% |
Chart calendar Galectin Therapeutics Inc.
d2cffad6fee0ce8e4c.sewZU9PIAIMhsy7kug5bPTrKq__bQ9NqgazYFS1p1kY.5IZ0NL75RORb1kGB1XojcGKB0sm3GZAzwv67RWMkiS3H3Fdr5YBW4kbKHg~586d54e6f253b1d5e8d0e519d955672e
Upcoming events on Galectin Therapeutics Inc.
Past events on Galectin Therapeutics Inc.
| 08/06/2024 07:30 | European Association for the Study of the Liver Congress - Abstract No: 2250, SAT-089 |
| 20/05/2024 21:00 | H.C. WainwrighT BioConnect Investor Conference |
| 15/05/2024 13:00 | Q1 2024 Earnings Release |
| 29/03/2024 12:00 | Q4 2023 Earnings Release |
| 07/12/2023 16:00 | Annual General Meeting |
| 13/11/2023 13:00 | Q3 2023 Earnings Release |
| 12/11/2023 13:00 | American Association for the Study of Liver Diseases Conference - Abstract Number : 3130-A |
| 12/11/2023 13:00 | American Association for the Study of Liver Diseases Conference - Abstract Number : 3079-A |
| 11/11/2023 13:00 | American Association for the Study of Liver Diseases Conference - Abstract Number : 2103-A |
| 11/11/2023 13:00 | American Association for the Study of Liver Diseases Conference - Abstract Number : 2269-C |
| 11/11/2023 13:00 | American Association for the Study of Liver Diseases Conference - Abstract Number : 2450-C |
| 24/10/2023 16:30 | H.C. Wainwright NASH Investor Conference |
| 27/09/2023 19:25 | Discovery on Target Meeting |
| 13/09/2023 17:00 | H.C. Wainwright Global Investment Conference |
| 06/09/2023 | Paris NASH Meeting |
| 14/08/2023 13:00 | Q2 2023 Earnings Release |
| 02/05/2023 15:30 | H.C. Wainwright BioConnect Investor Conference |
| 24/03/2023 | American Association for the Study of Liver Diseases Conference |
| 01/12/2022 16:00 | Annual General Meeting |
| 29/11/2022 | Obesity and NASH Drug Development Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -13,4 -11,8 -14.37% | -23,4 -24,6 4.75% | -30,2 -34,0 11.12% | -38,4 -38,0 -1.01% | -38,1 -38,2 0.36% | -41,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,3 -11,6 -14.63% | -23,5 -24,5 4.37% | -30,5 -34,7 12.08% | -38,8 -38,3 -1.3% | -41,1 -40,7 -1.01% | -40,7 |
|
Net income Million USD | Released Forecast Spread | -20,2 -15,0 -34.46% | -23,6 -24,6 4.1% | -30,7 -34,9 12.02% | -38,9 -38,4 -1.3% | -44,8 -44,4 -0.92% | -41,0 |
|
EPS USD | Released Forecast Spread | -0,39 -0,35 -11.43% | -0,41 -0,43 4.65% | -0,52 -0,59 11.86% | -0,65 -0,65 0% | -0,74 -0,74 0% | -0,66 |
| Announcement Date | 16/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,94 -8,10 -22.65% | -9,66 -11,0 12.16% | -8,12 -12,0 32.32% | -10,6 -10,3 -3.74% | -10,3 -12,5 17.26% | -9,00 -12,5 27.98% | -9,17 -9,50 3.52% | -9,56 -9,70 1.43% | -9,65 -10,1 4.48% | -10,1 | -10,5 | -10,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,93 -8,38 -18.59% | -9,61 -11,3 14.74% | -8,60 -11,9 27.67% | -10,6 -10,1 -4.92% | -11,5 -12,4 6.85% | -9,11 -12,4 26.35% | -10,4 -9,39 -11.11% | -10,00 -9,59 -4.3% | -11,5 -9,98 -15.18% | -9,98 | -10,4 | -10,4 |
|
Net income Million USD | Released Forecast Spread | -9,92 -8,38 -18.37% | -9,68 -11,3 14.66% | -8,58 -11,9 27.81% | -10,7 -10,2 -4.89% | -11,5 -12,4 6.87% | -9,18 -12,4 26.23% | -14,0 -9,39 -49.58% | -10,1 -9,65 -4.25% | -11,5 -10,0 -14.51% | -10,0 | -10,5 | -10,5 |
|
EPS USD | Released Forecast Spread | -0,17 -0,14 -21.43% | -0,16 -0,19 15.79% | -0,14 -0,20 30% | -0,18 -0,17 -5.88% | -0,19 -0,21 9.52% | -0,15 -0,21 28.57% | -0,24 -0,16 -50% | -0,16 -0,16 0% | -0,19 -0,16 -18.75% | -0,16 | -0,17 | -0,17 |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | 15/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Galectin Therapeutics Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GALT Stock
- Calendar Galectin Therapeutics Inc.
